Numinus Wellness
Company that markets psychedelic psychotherapy for mental health problems.
Launch date
Employees
Market cap
CAD9.6m
Enterprise valuation
CAD13m (Public information from Sep 2024)
Share price
CAD0.035 NUMI.TO
Vancouver British Columbia (HQ)
Financials
Estimates*
CAD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | 1.5m | 6.5m | 23.2m | 27.2m | 32.9m |
% growth | - | 720 % | 72 % | 329 % | 257 % | 17 % | 21 % |
EBITDA | (6.7m) | (6.6m) | (15.2m) | (26.5m) | (24.6m) | - | - |
% EBITDA margin | (6212 %) | (748 %) | (1001 %) | (408 %) | (106 %) | - | - |
Profit | (7.3m) | (9.6m) | (18.8m) | (44.9m) | (30.3m) | - | - |
% profit margin | (6762 %) | (1090 %) | (1240 %) | (691 %) | (131 %) | - | - |
R&D budget | <1m | <1m | 1.4m | 1.9m | 1.2m | - | - |
R&D % of revenue | 138 % | 21 % | 93 % | 29 % | 5 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
$4.5m | Early VC | ||
N/A | N/A | IPO | |
N/A | $17.3m | Post IPO Equity | |
* | CAD6.0m | Post IPO Equity | |
Total Funding | CAD6.2m |
Related Content
Recent News about Numinus Wellness
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Numinus Wellness
EditACQUISITION by Numinus Wellness Apr 2022
ACQUISITION by Numinus Wellness Jul 2021